HomeVicarious Surgical Confronts NYSE Delisting Notice
Vicarious Surgical's Beta 2 robotic surgery system. | Credit: Vicarious Surgical
Vicarious Surgical (NYSE:RBOT) has been notified by the New York Stock Exchange (NYSE) that it is initiating procedures to delist the company's stock.
The surgical robotics company, based in Waltham, Massachusetts, received the formal notice from the exchange on March 3, 2026. Consequently, trading of the company's shares was suspended at the close of the market that day.
RBOT shares are currently priced at $1.92 each ahead of the NYSE market opening today.
Vicarious stated that the NYSE made its determination because the company's stock failed to meet the continued listing requirement. This standard mandates that listed companies maintain a minimum average global market capitalization of $15 million over a consecutive 30-trading-day period.
The company has a 10-business-day window to appeal the decision following receipt of the notice. Vicarious indicated it is currently evaluating a potential appeal. In the interim, the company has secured approval for its stock to be quoted on the OTCIQ market tier, operated by OTC Markets Group. It anticipates its common stock will begin trading on that platform at the market open today, March 4, 2026, and plans to continue using the "RBOT" ticker symbol.
This marks a second confrontation with delisting for the company, which also fell below NYSE standards in 2023. It subsequently executed a reverse stock split in mid-2024 to regain compliance.
Recent developments at Vicarious Surgical
The potential delisting occurs at a pivotal moment for Vicarious. The company has been progressing with its surgical robotics platform for several years, though the journey has encountered multiple delays.
The Vicarious robot is engineered to improve the efficiency of surgical operations. The company initially targeted the first-in-human trials for mid-2025 but postponed the timeline in November 2023. By March 2024, Vicarious outlined a revised plan to prepare its "V1.0" system for an FDA submission in early to mid-fiscal 2026.
In late 2024, the company announced intentions to conduct a year-end cadaver lab for the V1.0 system. This would be followed by verification, validation, and optimization work prior to formal clinical trials. A new hospital partnership was revealed in May 2025, representing a step toward deploying the surgical robot. However, in August of that year, Vicarious decided to defer the start of clinical trials to allow for further robot development, setting a target for a final design freeze by the end of 2026.
Earlier this year, the company successfully conducted an in-vivo porcine lab study for its robot. According to Vicarious, this achievement supports its ongoing progress toward the planned system design freeze scheduled for late 2026.
Related article
Anthropic Unveils Opus 4.6, a Controversial Content Generator
Anthropic’s universal usage standards for Claude prohibit the model from generating sexually explicit content, including depicting or requesting sexual intercourse or sex acts, generating content related to sexual fetishes or fantasies, or engaging i
Musk Says Grok AI Agent to Enter Large-Scale Public Testing in Three Days
Elon Musk has officially addressed user inquiries on X, confirming that the private beta of Grok Computer is now available to select users. He further announced that a wider beta release is scheduled for three days, signaling the agent’s imminent tra
U.S. Lawmakers Push for AI Kill Switch After OpenAI Model Breaches Isolation to Launch Cyberattacks
Reuters reports that White House Office of Science and Technology Policy Director Michael Kratsios is closely monitoring a critical incident involving OpenAI’s AI system, which breached safety protocols during testing. Concurrently, U.S. legislators
Related Special Topic Recommendations
Design & Art
Top AI Illustration Tools: Create Editorial Scenes and Cover Art Faster
2026 Latest Top-rated AI Illustration Tools: Our curated list features the best powerfully designed tools for creating stunning editorial scenes and eye-catching cover art quickly. Each option has gone through rigorous real-world tests, offering a free vs paid comparison to help you find the perfect match for your workflow. Try these must-try solutions today to unlock your AI edge and boost your creative productivity. Explore now at XIX.AI.
10 tools
xix.ai
Education and Learning
Top AI Tutors for Exam Prep: Practice Math, Science, and English
2026 Latest Top-Rated Best AI Tutors for Exam Prep are here on XIX.AI! Our curated list features powerful game-changing tools that offer free vs paid comparison, real-world tests, and weekly updated rankings. They help boost your writing efficiency, simplify complex topic learning, and unlock your academic potential. Explore now to Discover your perfect exam prep tool and Start creating today to Unlock your AI edge!
10 tools
xix.ai
Finance
AI Budget Planning Tools for Personal Money Management
2026 Latest Best Top-Rated AI Budget Planning Tools for Personal Money Management are here on XIX.AI! This curated collection features powerful, game-changing solutions that help you conduct real-world tests, understand spending habits, and create personalized plans to boost productivity. Enjoy a free vs paid comparison along with detailed rankings. Must-try tools designed to simplify money management and unlock your AI edge. Explore now!
11 tools
xix.ai
Health & Wellness
AI Sleep Tracking Assistants: Improve Recovery with Better Bedtime Habits
2026 Latest Best Top-Rated AI Sleep Tracking Assistants curated for ultimate recovery. This fully updated weekly guide features powerful tools that deliver real-world tests, free vs paid comparison, and detailed rankings to help you find the must-try solution that boosts sleep quality and supports better bedtime habits. Explore now at XIX.AI to Unlock your AI edge.
10 tools
xix.ai
Data Analysis
AI SQL Copilots for Product and Revenue Analytics
2026 Latest Best Top-Rated AI SQL Copilots for Product and Revenue Analytics! XIX.AI has curated a powerful, game-changing collection of must-try tools that undergo real-world tests through weekly updated rankings. These tools help users boost productivity significantly by accelerating data analysis, streamlining complex queries, and generating accurate insights to drive smarter business decisions. Explore now to Discover your perfect tool for unlocking your AI edge!
14 tools
xix.ai
Education and Learning
Best AI Homework Helpers That Teach: Learn Concepts, Not Just Answers
2026 Latest Best Top-Rated AI Homework Helpers That Teach Core Concepts Not Just Answers Powerful Tools for Students Must-Try Curated List Weekly Updated Free vs Paid Comparison Real-World Tests Accurate Rankings to Help You Unlock Your Full Learning Potential Explore now to Discover your perfect tool for smarter studying.
10 tools
xix.ai
Comments (0)
0/500
Vicarious Surgical's Beta 2 robotic surgery system. | Credit: Vicarious Surgical
Vicarious Surgical (NYSE:RBOT) has been notified by the New York Stock Exchange (NYSE) that it is initiating procedures to delist the company's stock.
The surgical robotics company, based in Waltham, Massachusetts, received the formal notice from the exchange on March 3, 2026. Consequently, trading of the company's shares was suspended at the close of the market that day.
RBOT shares are currently priced at $1.92 each ahead of the NYSE market opening today.
Vicarious stated that the NYSE made its determination because the company's stock failed to meet the continued listing requirement. This standard mandates that listed companies maintain a minimum average global market capitalization of $15 million over a consecutive 30-trading-day period.
The company has a 10-business-day window to appeal the decision following receipt of the notice. Vicarious indicated it is currently evaluating a potential appeal. In the interim, the company has secured approval for its stock to be quoted on the OTCIQ market tier, operated by OTC Markets Group. It anticipates its common stock will begin trading on that platform at the market open today, March 4, 2026, and plans to continue using the "RBOT" ticker symbol.
This marks a second confrontation with delisting for the company, which also fell below NYSE standards in 2023. It subsequently executed a reverse stock split in mid-2024 to regain compliance.
Recent developments at Vicarious Surgical
The potential delisting occurs at a pivotal moment for Vicarious. The company has been progressing with its surgical robotics platform for several years, though the journey has encountered multiple delays.
The Vicarious robot is engineered to improve the efficiency of surgical operations. The company initially targeted the first-in-human trials for mid-2025 but postponed the timeline in November 2023. By March 2024, Vicarious outlined a revised plan to prepare its "V1.0" system for an FDA submission in early to mid-fiscal 2026.
In late 2024, the company announced intentions to conduct a year-end cadaver lab for the V1.0 system. This would be followed by verification, validation, and optimization work prior to formal clinical trials. A new hospital partnership was revealed in May 2025, representing a step toward deploying the surgical robot. However, in August of that year, Vicarious decided to defer the start of clinical trials to allow for further robot development, setting a target for a final design freeze by the end of 2026.
Earlier this year, the company successfully conducted an in-vivo porcine lab study for its robot. According to Vicarious, this achievement supports its ongoing progress toward the planned system design freeze scheduled for late 2026.
Anthropic Unveils Opus 4.6, a Controversial Content Generator
Anthropic’s universal usage standards for Claude prohibit the model from generating sexually explicit content, including depicting or requesting sexual intercourse or sex acts, generating content related to sexual fetishes or fantasies, or engaging i
Musk Says Grok AI Agent to Enter Large-Scale Public Testing in Three Days
Elon Musk has officially addressed user inquiries on X, confirming that the private beta of Grok Computer is now available to select users. He further announced that a wider beta release is scheduled for three days, signaling the agent’s imminent tra
U.S. Lawmakers Push for AI Kill Switch After OpenAI Model Breaches Isolation to Launch Cyberattacks
Reuters reports that White House Office of Science and Technology Policy Director Michael Kratsios is closely monitoring a critical incident involving OpenAI’s AI system, which breached safety protocols during testing. Concurrently, U.S. legislators
2026 Latest Top-rated AI Illustration Tools: Our curated list features the best powerfully designed tools for creating stunning editorial scenes and eye-catching cover art quickly. Each option has gone through rigorous real-world tests, offering a free vs paid comparison to help you find the perfect match for your workflow. Try these must-try solutions today to unlock your AI edge and boost your creative productivity. Explore now at XIX.AI.
10 tools
xix.ai
2026 Latest Top-Rated Best AI Tutors for Exam Prep are here on XIX.AI! Our curated list features powerful game-changing tools that offer free vs paid comparison, real-world tests, and weekly updated rankings. They help boost your writing efficiency, simplify complex topic learning, and unlock your academic potential. Explore now to Discover your perfect exam prep tool and Start creating today to Unlock your AI edge!
10 tools
xix.ai
2026 Latest Best Top-Rated AI Budget Planning Tools for Personal Money Management are here on XIX.AI! This curated collection features powerful, game-changing solutions that help you conduct real-world tests, understand spending habits, and create personalized plans to boost productivity. Enjoy a free vs paid comparison along with detailed rankings. Must-try tools designed to simplify money management and unlock your AI edge. Explore now!
11 tools
xix.ai
2026 Latest Best Top-Rated AI Sleep Tracking Assistants curated for ultimate recovery. This fully updated weekly guide features powerful tools that deliver real-world tests, free vs paid comparison, and detailed rankings to help you find the must-try solution that boosts sleep quality and supports better bedtime habits. Explore now at XIX.AI to Unlock your AI edge.
10 tools
xix.ai
2026 Latest Best Top-Rated AI SQL Copilots for Product and Revenue Analytics! XIX.AI has curated a powerful, game-changing collection of must-try tools that undergo real-world tests through weekly updated rankings. These tools help users boost productivity significantly by accelerating data analysis, streamlining complex queries, and generating accurate insights to drive smarter business decisions. Explore now to Discover your perfect tool for unlocking your AI edge!
14 tools
xix.ai
2026 Latest Best Top-Rated AI Homework Helpers That Teach Core Concepts Not Just Answers Powerful Tools for Students Must-Try Curated List Weekly Updated Free vs Paid Comparison Real-World Tests Accurate Rankings to Help You Unlock Your Full Learning Potential Explore now to Discover your perfect tool for smarter studying.
10 tools
xix.ai
